Cargando…

Ex vivo expanded natural killer cells from breast cancer patients and healthy donors are highly cytotoxic against breast cancer cell lines and patient-derived tumours

BACKGROUND: Natural killer (NK) cells play a critical role in cancer immunosurveillance. Recent developments in NK cell ex-vivo expansion makes it possible to generate millions of activated NK cells from a small volume of peripheral blood. We tested the functionality of ex vivo expanded NK cells in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shenouda, Mira M., Gillgrass, Amy, Nham, Tina, Hogg, Richard, Lee, Amanda J., Chew, Marianne V., Shafaei, Mahsa, Aarts, Craig, Lee, Dean A., Hassell, John, Bane, Anita, Dhesy-Thind, Sukhbinder, Ashkar, Ali A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5493877/ https://www.ncbi.nlm.nih.gov/pubmed/28668076 http://dx.doi.org/10.1186/s13058-017-0867-9

Ejemplares similares

Ex Vivo Expanded Human NK Cells Survive and Proliferate in Humanized Mice with Autologous Human Immune Cells
por: Vahedi, Fatemeh, et al.
Publicado: (2017)

Expanded human NK cells armed with CAR uncouple potent anti-tumor activity from off-tumor toxicity against solid tumors
por: Portillo, Ana L., et al.
Publicado: (2021)

Detection of Macrotroponin in Patients Receiving Treatment for Breast Cancer
por: Kavsak, Peter A., et al.
Publicado: (2023)

Overexpression of IL-15 promotes tumor destruction via NK1.1+ cells in a spontaneous breast cancer model
por: Gillgrass, Amy E, et al.
Publicado: (2015)

The effects of lymph node status on predicting outcome in ER+ /HER2- tamoxifen treated breast cancer patients using gene signatures
por: Cockburn, Jessica G., et al.
Publicado: (2016)

Targeted metabolomics in colorectal cancer: a strategic approach using standardized laboratory tests of the blood and urine
por: Jerzak, Katarzyna J, et al.
Publicado: (2017)

Statin therapy in the treatment of active cancer: A systematic review and meta-analysis of randomized controlled trials
por: Farooqi, Mohammed A. M., et al.
Publicado: (2018)

Real-Time Tracking of Ex Vivo-Expanded Natural Killer Cells Toward Human Triple-Negative Breast Cancers
por: Uong, Tung Nguyen Thanh, et al.
Publicado: (2018)

Feasibility outcomes of a randomised, multicentre, pilot trial comparing standard 6-monthly dosing of adjuvant zoledronate with a single one-time dose in patients with early stage breast cancer
por: Awan, Arif, et al.
Publicado: (2020)

A Gene Signature for Predicting Outcome in Patients with Basal-like Breast Cancer
por: Hallett, Robin M., et al.
Publicado: (2012)

Generalizability of toxicity data from oncology clinical trials to clinical practice: toxicity of irinotecan-based regimens in patients with metastatic colorectal cancer
por: Tam, V.C., et al.
Publicado: (2009)

Charting a killer course to the solid tumor: strategies to recruit and activate NK cells in the tumor microenvironment
por: Portillo, Ana L., et al.
Publicado: (2023)

Pertuzumab Cardiotoxicity in Patients With HER2-Positive Cancer: A Systematic Review and Meta-analysis
por: Alhussein, Muhammad Mustafa, et al.
Publicado: (2021)

Reconstitution of immune cell in liver and lymph node of adult- and newborn-engrafted humanized mice
por: Dykstra, Crystal, et al.
Publicado: (2016)

High Intensity Interval Training Increases Natural Killer Cell Number and Function in Obese Breast Cancer-challenged Mice and Obese Women
por: Barra, Nicole G., et al.
Publicado: (2017)

Serotonergic system antagonists target breast tumor initiating cells and synergize with chemotherapy to shrink human breast tumor xenografts
por: Gwynne, William D, et al.
Publicado: (2017)

Breaking silence: a survey of barriers to goals of care discussions from the perspective of oncology practitioners
por: Piggott, Katrina Lynn, et al.
Publicado: (2019)

Identification and evaluation of network modules for the prognosis of basal-like breast cancer
por: Hallett, Robin M., et al.
Publicado: (2015)

Inflammatory monocytes require type I interferon receptor signaling to activate NK cells via IL-18 during a mucosal viral infection
por: Lee, Amanda J., et al.
Publicado: (2017)

Claudin-Low Breast Cancer; Clinical & Pathological Characteristics
por: Dias, Kay, et al.
Publicado: (2017)

Three-Year Outcomes Following Permissive Cardiotoxicity in Patients on Trastuzumab
por: Zhou, Shijie, et al.
Publicado: (2023)

Cytotoxic effects of ex vivo-expanded natural killer cell-enriched lymphocytes (MYJ1633) against liver cancer
por: Choi, Jung-Won, et al.
Publicado: (2019)

Hypergravity-induced changes in actin response of breast cancer cells to natural killer cells
por: Lee, Minseon, et al.
Publicado: (2021)

Kaiso depletion attenuates the growth and survival of triple negative breast cancer cells
por: Bassey-Archibong, Blessing I, et al.
Publicado: (2017)

Why natural killer cells in triple negative breast cancer?
por: Abdel-Latif, Mustafa, et al.
Publicado: (2020)

Genital HSV-2 Infection Induces Short-Term NK Cell Memory
por: Abdul-Careem, Mohamed F., et al.
Publicado: (2012)

Identification of a Novel Luminal Molecular Subtype of Breast Cancer
por: Dvorkin-Gheva, Anna, et al.
Publicado: (2014)

Potent ex vivo expanded, human CD34+ cord blood-derived natural killer cells for cancer immunotherapy
por: Zhang, Xiaokui, et al.
Publicado: (2015)

The Role of Serotonin in Breast Cancer Stem Cells
por: Gwynne, William D., et al.
Publicado: (2021)

Potential Therapeutic Effect of Natural Killer Cells on Doxorubicin-Resistant Breast Cancer Cells In Vitro
por: Hwang, Mi-Hye, et al.
Publicado: (2015)

Breast cancer and dietary fat quality indices in Iranian women: A case–control study
por: Shafie, Fatemeh, et al.
Publicado: (2023)

Ex vivo expanded allogeneic natural killer cells have potent cytolytic activity against cancer cells through different receptor-ligand interactions
por: Jung, Daun, et al.
Publicado: (2021)

Clinical breast cancer and estrogen
por: Chew, HK
Publicado: (2003)

An Uncoupling of Canonical Phenotypic Markers and Functional Potency of Ex Vivo-Expanded Natural Killer Cells
por: Lieberman, Nicole A. P., et al.
Publicado: (2018)

Ex Vivo Chromosomal Radiosensitivity Testing in Patients with Pathological Germline Variants in Breast Cancer High-Susceptibility Genes BReast CAncer 1 and BReast CAncer 2
por: Zuhair Kassem, Tara, et al.
Publicado: (2023)

Neogenin expression is inversely associated with breast cancer grade in ex vivo
por: Xing, Wanying, et al.
Publicado: (2014)

T (1) Relaxation Measurement of Ex-Vivo Breast Cancer Tissues at Ultralow Magnetic Fields
por: Lee, Seong-Joo, et al.
Publicado: (2015)

E2F1 and KIAA0191 expression predicts breast cancer patient survival
por: Hallett, Robin M, et al.
Publicado: (2011)

Downregulation of CYB5D2 is associated with breast cancer progression
por: Ojo, Diane, et al.
Publicado: (2019)

Association between health literacy and adopting preventive behaviors of breast cancer in Iran
por: Panahi, Rahman, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_17u5mm1r5nam3uno316lsspneb